Jean-Paul Bonn

Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

MindSet Rx, Inc. operates as a biotech company that offers solution for neurodegenerative diseases. The company was founded by Bernard Malfroy-Camine and Michel Baudry in 2008 and is headquartered in Arlington, MA.

Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France.

Eukarion, Inc. engages in the provision of medical research. It develops small molecule drugs for the treatment of degenerative and age-related disorders. The company was founded on January 25, 1991 and is headquartered in Arlington, MA.

PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France.

Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France.

Part of Xiamen Comfort Science & Technology Group Co., Ltd., promed GmbH sells medical equipment for nail and skin care. The company is based in Farchant, Germany. The CEO of the German company is Andreas Schuster. promed was acquired by Medisana GmbH, part of Xiamen Comfort Science & Technology Group Co., Ltd. from October 27, 2016 on August 30, 2005 for $0.71 million.

Syngenta Biotechnology, Inc. provides genetics research and development services and is ultimately controlled by the Government of China. The company is based in Research Triangle Park, NC.

Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France.

Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.

Capital Grand Est SAS (Capital Grand Est) formerly known as Alsace Capital, is a private equity firm headquartered in France. Founded in 2012, the firm is wholly owned by Region Grand Est of France and has offices in Schiltigheim, France.

Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA.

Bionext SA develops software applications for pharmaceuticals and biotechnology companies. The firm integrates big data and cloud computing, and OMICS data through computer simulations for enabling to visualize, understand, and correct actions of drugs in human cells, as well as in drug discovery processes. The company was founded by Laurent-Philippe Albou and Serge Henri Albou in 2009 and is headquartered in Strasbourg, France.

Inoviem Scientific SAS offers preclinical and clinical services that use cutting-edge proprietary technologies to speed up drug-development. Its services include preclinical and drug discovery, patient stratification and biomarkers clinical development. The company was founded by Pierre Eftekhari in 2011 and is headquartered in Strasbourg, France.

Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France.

Adaptive Channel SAS develops a B2B2C digital content delivery solution to distribute various genres of content on to electronic devices. It offers adaptive content entertainment system that integrates content on its platform, such as newspapers and magazines, TV and film, music and games, corporate promotions, city guides, travel and lifestyle, advertising and retail, news and sports, and loyalty programs. The firm provides information technology development, implementation, support, and maintenance services, as well as information technology projects management, development, and training services; and customized hard support services. Adaptive Channel was founded in 2011 by David Fairand and is headquartered in Ramonville Saint Agne, France.

Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France.